Clinical Trial Update: EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study of EDP-494 in healthy subjects and Hepatitis C patients. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• EDP-494 (EDP-494)

Snippet

Sponsor: Enanta Pharmaceuticals, Inc | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED